TREATMENT WITH TOCILIZUMAB IMPROVED RHEUMATOID ARTHRITIS PATIENTS CLINICALLY AND STRUCTURALLY REGARDLESS OF THE PRIOR USE OF ANTI-TNF BIOLOGICS IN DAILY CLINICAL PRACTICE

被引：0
|
作者：
Izumi, K. [1 ]
Kaneko, Y. [1 ]
Yasuoka, H. [1 ]
Seta, N. [1 ]
Kameda, H. [1 ]
Kuwana, M. [1 ]
Takeuchi, T. [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：884 / 885
页数：2
相关论文
共 50 条
  • [41] TOCILIZUMAB IS CLINICALLY EFFECTIVE AND SAFE FOR HUMAN T-LYMPHOTROPIC VIRUS TYPE 1 POSITIVE PATIENTS WITH RHEUMATOID ARTHRITIS WHO ARE NOT RESPONSIVE TO ANTI-TNF TREATMENT
    Umekita, K.
    Hidaka, T.
    Miyauchi, S.
    Kubo, K.
    Hashiba, Y.
    Okayama, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 932 - 932
  • [42] Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFα treatment
    Harriman, G
    Harper, LK
    Schaible, TF
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 61 - 64
  • [43] Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry
    Harrold, Leslie R.
    Reed, George W.
    Shewade, Ashwini
    Magner, Robert
    Saunders, Katherine C.
    John, Ani
    Kremer, Joel M.
    Greenberg, Jeffrey D.
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1090 - 1098
  • [44] Clinical and experimental pain processing in rheumatoid arthritis patients treated with anti-TNF
    Wartolowska, K.
    Schweinhardt, P.
    Wordsworth, P.
    Chizh, B. A.
    Bountra, C.
    Chessell, I.
    Tracey, I.
    [J]. RHEUMATOLOGY, 2007, 46 : I6 - I7
  • [45] Do biologics-naive patients with rheumatoid arthritis respond better to tocilizumab than patients for whom anti-TNF agents have failed? A retrospective study
    Wakabayashi, H.
    Oka, H.
    Nishioka, Y.
    Hasegawa, M.
    Sudo, A.
    Nishioka, K.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 314 - 317
  • [46] Vascular endothelial dysfunction in rheumatoid arthritis is improved by anti-TNFα treatment with infliximab.
    Forster, A
    Hürlimann, D
    Ruschitzka, F
    Enseleit, F
    Noll, G
    Lüscher, TF
    Michel, N
    Distler, O
    Brühlmann, P
    Michel, BM
    Gay, RE
    Gay, S
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S511 - S511
  • [47] PERSISTENCE ON TREATMENT AND OPTIMIZATION AMONG ANTI-TNFα AGENTS IN PSORIATIC ARTHRITIS PATIENTS IN CLINICAL PRACTICE
    Pinto-Tasende, J.
    Alonso, E.
    Bejerano, C.
    Gromaz, J.
    Acasuso, B.
    Fernandez-Lopez, C.
    Oreiro, N.
    Acasuso, M.
    De Toro, J.
    Blanco, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1154 - 1155
  • [48] TREATMENT WITH ANTI-TNF BIOLOGICS IN PATIENT WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS DOES NOT INCREASE THE RISK OF MALIGNANCY
    Fanto, M.
    Peragallo, M.
    Pietrosanti, M.
    Sorgi, M. L.
    Salemi, S.
    D'Amelio, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 438 - 438
  • [49] Transcriptomic network analysis reveals key drivers of response to anti-TNF biologics in patients with rheumatoid arthritis
    Yu, Chae-Yeon
    Lee, Hye-Soon
    Bin Joo, Young
    Cho, Soo-Kyung
    Choi, Chan-Bum
    Sung, Yoon-Kyoung
    Kim, Tae-Hwan
    Jun, Jae-Bum
    Yoo, Dae Hyun
    Bae, Sang-Cheol
    Kim, Kwangwoo
    Bang, So-Young
    [J]. RHEUMATOLOGY, 2023, : 1422 - 1431
  • [50] Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatment
    Emery, Paul
    [J]. RHEUMATOLOGY, 2012, 51 : V22 - V30
12345